Company profile
Kasvu Therapeutics
Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered
- Location
- Helsinki, Southern Finland, Finland, Europe
- Website
- kasvutx.com
Latest known funding
Series A round
- Capital
- $34.2M
- Announced
- Sep 24, 2026